Advertisement

Loading...

Reyna Silver Corp.

RSNVFPNK
$0.09
$0.00(0.00%)
U.S. Market opens in 14h 3m

Reyna Silver Corp. Fundamental Analysis

Reyna Silver Corp. (RSNVF) shows weak financial fundamentals with a PE ratio of -5.00, profit margin of 0.00%, and ROE of -49.21%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

PEG Ratio-0.07
Current Ratio1.86

Areas of Concern

ROE-49.21%
Operating Margin0.00%
We analyze RSNVF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -19.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-19.9/100

We analyze RSNVF's fundamental strength across five key dimensions:

Efficiency Score

Weak

RSNVF struggles to generate sufficient returns from assets.

ROA > 10%
-50.14%

Valuation Score

Excellent

RSNVF trades at attractive valuation levels.

PE < 25
-5.00
PEG Ratio < 2
-0.07

Growth Score

Moderate

RSNVF shows steady but slowing expansion.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
15.26%

Financial Health Score

Excellent

RSNVF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
1.86

Profitability Score

Weak

RSNVF struggles to sustain strong margins.

ROE > 15%
-4921.31%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is RSNVF Expensive or Cheap?

P/E Ratio

RSNVF trades at -5.00 times earnings. This suggests potential undervaluation.

-5.00

PEG Ratio

When adjusting for growth, RSNVF's PEG of -0.07 indicates potential undervaluation.

-0.07

Price to Book

The market values Reyna Silver Corp. at 2.76 times its book value. This may indicate undervaluation.

2.76

EV/EBITDA

Enterprise value stands at -11.30 times EBITDA. This is generally considered low.

-11.30

How Well Does RSNVF Make Money?

Net Profit Margin

For every $100 in sales, Reyna Silver Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-49.21 in profit for every $100 of shareholder equity.

-49.21%

ROA

Reyna Silver Corp. generates $-50.14 in profit for every $100 in assets, demonstrating efficient asset deployment.

-50.14%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

RSNVF converts -4.00% of its market value into free cash.

-4.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-5.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.07

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.76

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.86

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.49

vs 25 benchmark

ROA

Return on assets percentage

-0.50

vs 25 benchmark

ROCE

Return on capital employed

-0.29

vs 25 benchmark

How RSNVF Stacks Against Its Sector Peers

MetricRSNVF ValueSector AveragePerformance
P/E Ratio-5.0024.02 Better (Cheaper)
ROE-49.21%867.00% Weak
Net Margin0.00%-102872.00% (disorted) Weak
Debt/Equity0.000.51 Strong (Low Leverage)
Current Ratio1.865.08 Neutral
ROA-50.14%-6488.00% (disorted) Weak

RSNVF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Reyna Silver Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Cyclical, Commodity, Value

Declining

EPS CAGR

-647.46%

Industry Style: Cyclical, Commodity, Value

Declining

FCF CAGR

-2566.62%

Industry Style: Cyclical, Commodity, Value

Declining

Fundamental Analysis FAQ